In nature, lectins are widely dispersed proteins that selectively recognize and bind to
carbohydrates and glycoconjugates via reversible bonds at specific binding sites. Many viral …

Many natural lectins have been reported to have antiviral activity. As some of these have
been put forward as potential development candidates for preventing or treating viral …

Antibody based products are not widely available to address multiple global health
challenges due to high costs, limited manufacturing capacity, and long manufacturing lead …

The entry of enveloped viruses into their host cells involves several successive steps, each
one being amenable to therapeutic intervention. Entry inhibitors act by targeting viral and/or …

Plant-based transient overexpression systems enable rapid and scalable production of
subunit vaccines. Previously, we have shown that cholera toxin B subunit (CTB), an oral …

A combination of prevention and treatment modalities will be needed to successfully control
the global spread of HIV. Microbicides, drug products topically applied to mucosal surfaces …

Agrobacterium-mediated transient expression systems enable plants to produce a wide
range of recombinant proteins on a rapid timescale. To achieve economically feasible …

A review of the recent outcomes regarding technologies to prevent vaginal transmission of
HIV, mainly by using antiretroviral (ARV) drugs formulated as microbicides. An introduction …

Aberrant protein glycosylation is a hallmark of cancer, but few drugs targeting cancer
glycobiomarkers are currently available. Here, we showed that a lectibody consisting of the …

Introduction Cholera toxin B subunit (CTB) is a component of an internationally licensed oral
cholera vaccine. The protein induces neutralizing antibodies against the holotoxin, the …